Bio-Rad Laboratories, Inc. 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-04 7:06 pm Purchase | 2025-02-10 | 13G | ONCOCYTE CORPORATION OCX | BIO-RAD LABORATORIES INC. BIO | 2,764,078 9.700% | 1,253,134 (+82.94%) | Filing |